HYPOTHERMIC CIRCULATORY ARREST
低温循环骤停
基本信息
- 批准号:6241224
- 负责人:
- 金额:$ 11.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-01 至 1998-06-30
- 项目状态:已结题
- 来源:
- 关键词:aerobiosis allopurinol bioenergetics brain injury brain metabolism calcium calcium channel blockers cerebral ischemia /hypoxia chemoprevention divalent cations dogs free radical scavengers glutamates glycolysis heart surgery histopathology hyperglycemia induced hypothermia microdialysis neuroprotectants newborn animals nuclear magnetic resonance spectroscopy perinatal thiopental
项目摘要
This experimental protocol, to be conducted in newborn dogs, was designed
to elucidate the manner and extent to which the immature brain is
protected from ischemic damage during hypothermic circulatory arrest.
The rationale for this line of research relates to the well-established
approach to the surgical repair of congenital cardiac defects. Specific
aims include: 1) to characterize the early evolution of ischemic brain
damage which results from prolonged hypothermic circulatory arrest in
newborn dogs and to determine whether or not a delayed neuronal necrosis
occurs; 2) to investigate underlying mechanisms which protect the
perinatal ischemic brain from injury during hypothermic circulatory
arrest other than or in addition to a suppression of oxidative
metabolism; 3) to compare the extent to which incomplete versus complete
cerebral ischemia is protective (or deleterious) to newborn dog brain
during hypothermia; 4) to ascertain the beneficial or deleterious effect
of hyperglycemia on the brain damage which results from hypothermic
circulatory arrest in newborn dogs; and 5) to determine the protective
influence of specific therapeutic modalities on ischemic brain damage
resulting from hypothermic circulatory arrest in newborn dogs.
Experimental procedures will involve the induction of hypothermia by
surface cooling in anesthetized, paralyzed and artifically ventilated
newborn dogs to 20degreesC followed by cardiac arrest for up to 120
minutes. Thereafter, the animals will be resuscitated, following which
they will undergo neuropathologic analysis at specific intervals of
recovery. Regional oxidative and energy metabolism will be determined
during and following hypothermic circulatory arrest by the in situ
analysis of concentrations of selected glycolytic and Krebs cycle
intermediates and high-energy phosphate compounds, using enzymatic,
fluorometric techniques. 31P MR spectroscopy also will be used to
measure sequentially cerebral high-energy phosphate reserves and
intracellular pH (pHi) during and following hypothermic circulatory
arrest. Extracellular concentrations of excitatory and inhibitory
neurotransmitters also will be measured using a microdialysis technique.
Lastly, the regional accumulation of calcium in brain during and
following hypothermic circulatory arrest will be accomplished using
[45Ca]-autoradiography. Therapeutic interventions to potentially reduce
the extent of brain damage during hypothermic circulatory arrest will
include thiopental sodium, the xanthine oxidase inhibitor, oxypurinol,
and the calcium channel blocker, nimodipine. Additional experimental
protocols include the induction of a 'low flow' rather that a 'no flow'
state and the determination of the effect of hyperglycemia on hypothermic
ischemic brain damage. It is anticipated that these investigations will
provide insight into the physiochemical mechanism(s) and duration of the
protective influence of hypothermia on circulatory arrest.
本实验方案在新生犬中进行,
来阐明未成熟的大脑
在低温停循环期间免受缺血性损伤。
这一系列研究的基本原理与公认的
先天性心脏缺损的外科修复方法。 具体
目的包括:1)表征缺血性脑的早期演变
长时间低温停循环造成的损害,
新生狗,并确定是否有迟发性神经元坏死
发生; 2)调查保护的潜在机制,
围生期脑缺血与低温循环损伤
除了抑制氧化抑制之外的抑制
3)比较不完全与完全代谢的程度,
脑缺血对新生犬脑有保护作用(或有害作用)
在低温期间; 4)确定有益或有害的影响
高血糖对脑损伤的影响,
新生犬循环停止; 5)确定保护性
特异性治疗方法对缺血性脑损伤的影响
新生狗的低温循环停止引起的
实验程序将涉及通过以下方法诱导体温降低:
麻醉、麻痹和人工通气下的表面冷却
新生狗在20 ℃下心脏骤停达120
分钟 之后,动物将复苏,
他们将在特定的时间间隔进行神经病理学分析,
复苏 将确定区域氧化和能量代谢
原位低温停循环期间和之后
选择的糖酵解和克雷布斯循环的浓度分析
中间体和高能磷酸盐化合物,使用酶,
荧光技术。 31 P MR光谱也将用于
连续测量大脑高能磷酸盐储备,
低温循环过程中和之后细胞内pH(pHi)
逮捕了 兴奋性和抑制性的细胞外浓度
还将使用微透析技术测量神经递质。
最后,脑内钙的区域性积聚,
在低温停循环后,将使用
[45 Ca]-放射自显影。 治疗性干预措施,
低温停循环过程中脑损伤的程度
包括硫喷妥钠、黄嘌呤氧化酶抑制剂、羟嘌呤醇
和钙通道阻滞剂尼莫地平 另外的实验
方案包括诱导“低流量”而不是“无流量”
状态和高血糖对低体温影响的测定
缺血性脑损伤 预计这些调查将
提供对生理化学机制和持续时间的深入了解,
低温对循环停止的保护作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT C. VANNUCCI其他文献
ROBERT C. VANNUCCI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT C. VANNUCCI', 18)}}的其他基金
REGIONAL CEREBRAL BLOOD FLOW AND OXIDATIVE METABOLISM
区域脑血流和氧化代谢
- 批准号:
6272279 - 财政年份:1998
- 资助金额:
$ 11.69万 - 项目类别:
相似国自然基金
Apocynin和allopurinol对运动上调自发性高血压大鼠肾脏一氧化氮合成酶表达的影响
- 批准号:81301667
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Allopurinol Improves Diastolic Function in African Americans with Resistant Hypertension
别嘌呤醇可改善患有难治性高血压的非裔美国人的舒张功能
- 批准号:
10701217 - 财政年份:2023
- 资助金额:
$ 11.69万 - 项目类别:
Association Between Allopurinol and Cardiovascular Events, Mortality and End-Stage Renal Disease in Diabetes
别嘌呤醇与糖尿病心血管事件、死亡率和终末期肾病之间的关联
- 批准号:
377029 - 财政年份:2017
- 资助金额:
$ 11.69万 - 项目类别:
Fellowship Programs
CKD-FIX: a randomised, controlled trial of allopurinol in the slowing of kidney disease progression
CKD-FIX:别嘌呤醇减缓肾脏疾病进展的随机对照试验
- 批准号:
nhmrc : GNT1043203 - 财政年份:2013
- 资助金额:
$ 11.69万 - 项目类别:
Project Grants
PERL: A multi-center clinical trial of allopurinol to prevent GFR loss in T1D
PERL:别嘌呤醇预防 T1D 患者 GFR 损失的多中心临床试验
- 批准号:
9738022 - 财政年份:2013
- 资助金额:
$ 11.69万 - 项目类别:
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
PERL:别嘌呤醇预防 T1D 患者 GFR 损失的多中心临床试验
- 批准号:
8644403 - 财政年份:2013
- 资助金额:
$ 11.69万 - 项目类别:
A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
别嘌呤醇预防 1 型糖尿病 GFR 损失的多中心临床试验
- 批准号:
8445008 - 财政年份:2012
- 资助金额:
$ 11.69万 - 项目类别:
Design of a Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
别嘌呤醇预防 1 型糖尿病 GFR 损失的多中心临床试验设计
- 批准号:
8250159 - 财政年份:2011
- 资助金额:
$ 11.69万 - 项目类别:
Analysis of the mechanisms of allopurinol-induced severe cutaneous adverse reactions
别嘌呤醇致严重皮肤不良反应的机制分析
- 批准号:
23790611 - 财政年份:2011
- 资助金额:
$ 11.69万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
ALLOPURINOL AND CARDIAC FUNCTION IN IDIOPATHIC DILATED CARDIOMYOPATHY
特发性扩张型心肌病中别嘌呤醇与心脏功能
- 批准号:
7199117 - 财政年份:2004
- 资助金额:
$ 11.69万 - 项目类别:
ALLOPURINOL AND THE PREVENTION OF DEATH, TISSUE INJURY, AND SEIZURES IN CHD
别嘌呤醇与预防冠心病死亡、组织损伤和癫痫发作
- 批准号:
6116864 - 财政年份:1998
- 资助金额:
$ 11.69万 - 项目类别: